Chaloupka B - Search Results

1

A novel insulinoma tumor suppressor gene locus on chromosome 22q with potential prognostic implications.

Wild A, Langer P, Ramaswamy A, Chaloupka B, Bartsch DK. Wild A, et al. Among authors: chaloupka b. J Clin Endocrinol Metab. 2001 Dec;86(12):5782-7. doi: 10.1210/jcem.86.12.8089. J Clin Endocrinol Metab. 2001. PMID: 11739439

2

Chromosome 22q in pancreatic endocrine tumors: identification of a homozygous deletion and potential prognostic associations of allelic deletions.

Wild A, Langer P, Celik I, Chaloupka B, Bartsch DK. Wild A, et al. Among authors: chaloupka b. Eur J Endocrinol. 2002 Oct;147(4):507-13. doi: 10.1530/eje.0.1470507. Eur J Endocrinol. 2002. PMID: 12370114

3

Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors.

Wild A, Ramaswamy A, Langer P, Celik I, Fendrich V, Chaloupka B, Simon B, Bartsch DK. Wild A, et al. Among authors: chaloupka b. J Clin Endocrinol Metab. 2003 Mar;88(3):1367-73. doi: 10.1210/jc.2002-021027. J Clin Endocrinol Metab. 2003. PMID: 12629131

4

Alterations of the tissue inhibitor of metalloproteinase-3 (TIMP3) gene in pancreatic adenocarcinomas.

Fendrich V, Slater EP, Heinmöller E, Ramaswamy A, Celik I, Nowak O, Chaloupka B, Gerdes B, Bartsch DK. Fendrich V, et al. Among authors: chaloupka b. Pancreas. 2005 Mar;30(2):e40-5. doi: 10.1097/01.mpa.0000153325.62192.8a. Pancreas. 2005. PMID: 15714128

5

Clinical impact of TP53 alterations in adrenocortical carcinomas.

Waldmann J, Patsalis N, Fendrich V, Langer P, Saeger W, Chaloupka B, Ramaswamy A, Fassnacht M, Bartsch DK, Slater EP. Waldmann J, et al. Among authors: chaloupka b. Langenbecks Arch Surg. 2012 Feb;397(2):209-16. doi: 10.1007/s00423-011-0868-6. Epub 2011 Dec 29. Langenbecks Arch Surg. 2012. PMID: 22203015

6

Higher frequency of DPC4/Smad4 alterations in pancreatic cancer cell lines than in primary pancreatic adenocarcinomas.

Bartsch D, Barth P, Bastian D, Ramaswamy A, Gerdes B, Chaloupka B, Deiss Y, Simon B, Schudy A. Bartsch D, et al. Among authors: chaloupka b. Cancer Lett. 1999 May 3;139(1):43-9. doi: 10.1016/s0304-3835(98)00380-2. Cancer Lett. 1999. PMID: 10408907

7

Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.

Bartsch DK, Langer P, Habbe N, Matthäi E, Chaloupka B, Sina M, Hahn SA, Slater EP. Bartsch DK, et al. Among authors: chaloupka b. Clin Genet. 2010 Apr;77(4):333-41. doi: 10.1111/j.1399-0004.2009.01352.x. Epub 2009 Dec 22. Clin Genet. 2010. PMID: 20041885

8

LCN2 and TIMP1 as Potential Serum Markers for the Early Detection of Familial Pancreatic Cancer.

Slater EP, Fendrich V, Strauch K, Rospleszcz S, Ramaswamy A, Mätthai E, Chaloupka B, Gress TM, Langer P, Bartsch DK. Slater EP, et al. Among authors: chaloupka b. Transl Oncol. 2013 Apr;6(2):99-103. doi: 10.1593/tlo.12373. Epub 2013 Apr 1. Transl Oncol. 2013. PMID: 23544163 Free PMC article.

9

Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.

Bartsch DK, Slater EP, Albers M, Knoop R, Chaloupka B, Lopez CL, Fendrich V, Kann PH, Waldmann J. Bartsch DK, et al. Among authors: chaloupka b. J Clin Endocrinol Metab. 2014 Nov;99(11):E2387-91. doi: 10.1210/jc.2013-4432. Epub 2014 Sep 11. J Clin Endocrinol Metab. 2014. PMID: 25210877

10

Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families.

Slater EP, Langer P, Fendrich V, Habbe N, Chaloupka B, Matthäi E, Sina M, Hahn SA, Bartsch DK. Slater EP, et al. Among authors: chaloupka b. Fam Cancer. 2010 Sep;9(3):335-43. doi: 10.1007/s10689-010-9329-6. Fam Cancer. 2010. PMID: 20195775

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters